4th Quarter - Report
THE D MAJOR GROUP for EMD SERONO, INC.
Firm
Client
Income
$40,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
Work on pharmaceutical reporting matters related to H.R. 133, the "Consolidated Appropriations Act of 2021."
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Medicare/Medicaid MMM
Monitor Medicare Part B & D policy changes related to S. 2543, the Prescription Drug Pricing Reduction Act; HR 3, Lower Drug Costs Now Act; and S. 3129 and HR 19, the Lower Costs, More Cures Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Copyright/Patent/Trademark CPT
Monitor pharmaceutical R&D investment issues related patent protection.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DIANE MAJOR | Health Policy Analyst for Senate Republican Policy Committee |
| BRENDA REESE | Conference Coordinator for House Republican Conference |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.